During the past decade, Biomedical Research Alliance of New York conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Biomedical Research Alliance of New York" are "ESRD" (1 trials), "Kidney Diseases" (1 trials), "Oral Mucositis" (1 trials) and "Stomatitis" (1 trials). Many other conditions were trialed in "Biomedical Research Alliance of New York" in a lesser frequency.

Most popular intervention types in "Biomedical Research Alliance of New York" are "Device" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Lifespan® ePTFE Vascular Graft" (1 trials), "Vascular Wrap Paclitaxel-Eluting Mesh" (1 trials), "placebo" (1 trials) and "velafermin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Biomedical Research Alliance of New York" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Biomedical Research Alliance of New York". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Biomedical Research Alliance of New York, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Biomedical Research Alliance of New York, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".